UnknownNot Applicable

Efficacy and Safety of Plasma Exchange Compared to Standard Medical Therapy in Patients With Severe Drug Induced Liver Injury With or Without Underlying Chronic Liver Disease.

India30 participantsStarted 2019-07-09

Plain-language summary

In this randomized study subject will be randomized into two groups Group A will receive Standard Medical Treatment (Albumin + High Caloric Diet) Group B will continue Standard Medical Treatment with High Volume Plasma Exchange. All other interventions will be at the discretion of clinicians.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Grade IV DILI With T.B \> 15
✓. DILI Manifesting as ACLF (Acute on chronic Liver failure) /ALF (Acute Liver Failure) with no transplant option

What they're measuring

Transplant free survival in both group

Timeframe: Day 28

Trial details

NCT IDNCT04015570

SponsorInstitute of Liver and Biliary Sciences, India

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-07-01

Contact for this trial

Dr Satyam Sinha, MD

01146300000 satyamsinhacmc5@gmail.com

View on ClinicalTrials.gov More Chronic Liver Disease trials